CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...